First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrad...
Pilot study on outcome and antitumor efficacy of an autologous cancer cell vacci...
A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8...
Randomized phase III study to evaluate the impact of secondary cytoreductive sur...
TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versu...
IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezo...
Transoral robotic surgical resection followed by randomization to low- or standa...
The oncology hospital at home: Health care utilization outcomes from the huntsma...
1Department of Biological Sciences, Ashoka University, Sonepat, Haryana 131029, ...
Research Group of Proteomics and ADP-ribosylation Signaling, Max Planck Institut...
